IL-13 improves beta-cell survival and protects against IL-1beta-induced beta-cell death

Molecular Metabolism

Volumn 5, Issue 2, 2016, Pages 122-131

  Rütti, Sabine ^a,b   Howald, Cédric ^a   Arous, Caroline ^a   Dermitzakis, Emmanouil ^a   Halban, Philippe A ^a   Bouzakri, Karim ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Akt; Apoptosis; Beta cells; Cytokines; Gene expression

Indexed keywords

GAMMA INTERFERON; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN RECEPTOR SUBSTRATE 2; INTERLEUKIN 13; INTERLEUKIN 1BETA; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CELL PROTECTION; CELL STRESS; CELL SURVIVAL; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; INSULIN RELEASE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

EID: 84958078161     PISSN: 22128778     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmet.2015.11.003     Document Type: Article

References (37)

1. Prentki M., Nolan C.J. Islet beta cell failure in type 2 diabetes. Journal of Clinical Investigation 2006, 116(7):1802-1812.
2. Donath M.Y., Halban P.A. Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications. Diabetologia 2004, 47(3):581-589.
3. Donath M.Y., Shoelson S.E. Type 2 diabetes as an inflammatory disease. Nature Reviews Immunology 2011, 11(2):98-107.
4. Donath M.Y., Boni-Schnetzler M., Ellingsgaard H., Halban P.A., Ehses J.A. Cytokine production by islets in health and diabetes: cellular origin, regulation and function. Trends in Endocrinology & Metabolism 2010, 21(5):261-267.
5. Rutti S., Arous C., Schvartz D., Timper K., Sanchez J.C., Dermitzakis E., et al. Fractalkine (CX3CL1), a new factor protecting beta-cells against TNFalpha. Molecular Metabolism 2014, 3(7):731-741.
6. Kwon H., Laurent S., Tang Y., Zong H., Vemulapalli P., Pessin J.E. Adipocyte-specific IKKbeta signaling suppresses adipose tissue inflammation through an IL-13-dependent paracrine feedback pathway. Cell Reports 2014.
7. Russell M.A., Morgan N.G. The impact of anti-inflammatory cytokines on the pancreatic beta-cell. Islets 2014, 6(3):e950547.
8. Kelly-Welch A.E., Hanson E.M., Boothby M.R., Keegan A.D. Interleukin-and interleukin-13 signaling connections maps. Science 2003, 300(5625):1527-1528.
9. Wills-Karp M., Finkelman F.D. Untangling the complex web of IL-4- and IL-13-mediated signaling pathways. Science Signaling 2008, 1(51). pe55.
10. Stanya K.J., Jacobi D., Liu S., Bhargava P., Dai L., Gangl M.R., et al. Direct control of hepatic glucose production by interleukin-13 in mice. Journal of Clinical Investigation 2013, 123(1):261-271.
11. Jiang L.Q., Franck N., Egan B., Sjogren R.J., Katayama M., Duque-Guimaraes D., et al. Autocrine role of interleukin-13 on skeletal muscle glucose metabolism in type 2 diabetic patients involves microRNA let-7. American Journal of Physiology Endocrinology & Metabolism 2013, 305(11):E1359-E1366.
12. Russell M.A., Cooper A.C., Dhayal S., Morgan N.G. Differential effects of interleukin-13 and interleukin-on Jak/STAT signaling and cell viability in pancreatic beta-cells. Islets 2013, 5(2):95-105.
13. Souza K.L., Gurgul-Convey E., Elsner M., Lenzen S. Interaction between pro-inflammatory and anti-inflammatory cytokines in insulin-producing cells. Journal of Endocrinology 2008, 197(1):139-150.
14. Sternesjo J., Sandler S. Interleukin-13 counteracts suppression induced by interleukin-1beta of glucose metabolism but not of insulin secretion in rat pancreatic islets. Autoimmunity 1997, 26(3):153-159.
15. Parnaud G., Bosco D., Berney T., Pattou F., Kerr-Conte J., Donath M.Y., et al. Proliferation of sorted human and rat beta cells. Diabetologia 2008, 51(1):91-100.
16. Nica A.C., Ongen H., Irminger J.C., Bosco D., Berney T., Antonarakis S.E., et al. Cell-type, allelic, and genetic signatures in the human pancreatic beta cell transcriptome. Genome Research 2013, 23(9):1554-1562.
17. Marco-Sola S., Sammeth M., Guigo R., Ribeca P. The GEM mapper: fast, accurate and versatile alignment by filtration. Nature Methods 2012, 9(12):1185-1188.
18. Center de Regulation Genomica, B. 2008.
19. Love M.I., Huber W., Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biology 2014, 15(12):550.
20. Tomas A., Yermen B., Min L., Pessin J.E., Halban P.A. Regulation of pancreatic beta-cell insulin secretion by actin cytoskeleton remodelling: role of gelsolin and cooperation with the MAPK signalling pathway. Journal of Cell Science 2006, 119(Pt 10):2156-2167.
21. Rutti S., Sauter N.S., Bouzakri K., Prazak R., Halban P.A., Donath M.Y. In vitro proliferation of adult human beta-cells. PLoS One 2012, 7(4):e35801.
22. Li W., Xu H., Xiao T., Cong L., Love M.I., Zhang F., et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens. Genome Biology 2014, 15(12):554.
23. Rondas D., Tomas A., Halban P.A. Focal adhesion remodeling is crucial for glucose-stimulated insulin secretion and involves activation of focal adhesion kinase and paxillin. Diabetes 2011, 60(4):1146-1157.
24. Huang D., Khoe M., Befekadu M., Chung S., Takata Y., Ilic D., et al. Focal adhesion kinase mediates cell survival via NF-kappaB and ERK signaling pathways. American Journal of Physiology Cell Physiology 2007, 292(4):C1339-C1352.
25. Trengove M.C., Ward A.C. SOCS proteins in development and disease. American Journal of Clinical and Experimental Immunology 2013, 2(1):1-29.
26. Boni-Schnetzler M., Thorne J., Parnaud G., Marselli L., Ehses J.A., Kerr-Conte J., et al. Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta-cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation. The Journal of Clinical Endocrinology & Metabolism 2008, 93(10):4065-4074.
27. Terauchi Y., Takamoto I., Kubota N., Matsui J., Suzuki R., Komeda, et al. Glucokinase and IRS-are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance. Journal of Clinical Investigation 2007, 117(1):246-257.
28. Kowluru A., Kowluru R.A. Phagocyte-like NADPH oxidase [Nox2] in cellular dysfunction in models of glucolipotoxicity and diabetes. Biochemical Pharmacology 2014, 88(3):275-283.
29. Li N., Li B., Brun T., Deffert-Delbouille C., Mahiout Z., Daali Y., et al. NADPH oxidase NOX2 defines a new antagonistic role for reactive oxygen species and cAMP/PKA in the regulation of insulin secretion. Diabetes 2012, 61(11):2842-2850.
30. Eizirik D.L., Miani M., Cardozo A.K. Signalling danger: endoplasmic reticulum stress and the unfolded protein response in pancreatic islet inflammation. Diabetologia 2013, 56(2):234-241.
31. Cheung L., Zervou S., Mattsson G., Abouna S., Zhou L., Ifandi V., et al. c-Myc directly induces both impaired insulin secretion and loss of beta-cell mass, independently of hyperglycemia in vivo. Islets 2010, 2(1):37-45.
32. Tan B.K., Adya R., Randeva H.S. Omentin: a novel link between inflammation, diabesity, and cardiovascular disease. Trends in Cardiovascular Medicine 2010, 20(5):143-148.
33. Kataoka Y., Shibata R., Ohashi K., Kambara T., Enomoto T., Uemura Y., et al. Omentin prevents myocardial ischemic injury through AMP-activated protein kinase- and Akt-dependent mechanisms. Journal of the American College of Cardiology 2014, 63(24):2722-2733.
34. Wu C., Shan Y., Liu X., Song W., Wang J., Zou M., et al. GalNAc-T14 may be involved in regulating the apoptotic action of IGFBP-3. Journal of Biosciences 2009, 34(3):389-395.
35. Lu J., Gu J. Significance of beta-galactoside alpha2,6 sialyltranferase 1 in cancers. Molecules 2015, 20(5):7509-7527.
36. Donath M.Y., Burcelin R. GLP-effects on islets: hormonal, neuronal, or paracrine?. Diabetes Care 2013, 36(Suppl. 2):S145-S148.
37. Thorel F., Nepote V., Avril I., Kohno K., Desgraz R., Chera S., et al. Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss. Nature 2010, 464(7292):1149-1154.